Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
Stock News TikTok inks U.S. spinoff deal: Oracle (ORCL) and partners Silver Lake and MGX will take major stakes in a new TikTok U.S. venture, with U.S. data hos
Addenda Capital Inc. increased its position in Merck and Co., Inc. (NYSE: MRK) by 26.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities an
Merck and Co., Inc. (NYSE: MRK - Get Free Report)'s stock price traded up 1.6% on Thursday after BMO Capital Markets upgraded the stock from a market perform rating to an outperform rating. BMO Capita
Merck is reiterated as a buy, with the price target raised to $114, reflecting robust Q3 results and strong technical momentum. Q3 saw non-GAAP EPS of $2.58 (vs. $2.35 consensus) and revenue of $17.3B

Merck (MRK) Rises Higher Than Market: Key Facts

06:51pm, Thursday, 18'th Dec 2025
In the latest trading session, Merck (MRK) closed at $100.69, marking a +1.52% move from the previous day.
Guru Stock PicksCI Select Canadian Equity Fund has made the following transactions:Reduce in TSX: ABX by 9.95%Sold out in TSX:DOLAdd in TSX: KEY by 27.62%New posi
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales.
Pre-Market Stock Futures: Futures are trading higher on Thursday as we grind closer to the Christmas holiday, which is just a week off now. The song remains the same for the AI/Datacenter trade, and p
Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Merck and Co., Inc. (NYSE: MRK). In a filing disclosed on December 15th, the Representative disclosed that they had bo
The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with multibillion-dollar potential, according to internal documents seen by Reuters.
Merck & Co. Inc. (NYSE: MRK) on Wednesday shared topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for c
Pfizer Inc (NYSE: PFE) and Merck & Co Inc (NYSE: MRK) aren't exciting stocks anymore — and after a bruising reset, that's starting to look intentional. Pfizer's stock has been back in focus this mon
Pfizer has a substantial 6.6% dividend yield but a payout ratio exceeding 100%. Eli Lilly has a payout ratio of roughly 30%, but its dividend yield is a tiny 0.6%.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE